CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 11 enrolled
Drug / intervention
Platelet-rich plasma +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04941807
NCT04941807Phase 4Completed
CompareCT.gov

Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

Weill Medical College of Cornell University·interventional·Posted Jun 28, 2021·Updated Apr 23, 2024

In Brief

A Phase 4 clinical trial evaluating Platelet-rich plasma and Platelet-poor plasma for Nail Diseases. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the efficacy and safety of platelet-rich plasma therapy for brittle nail syndrome

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNail Diseases
CountriesUnited States
CollaboratorsEclipse Aesthetics, LLC

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedJun 28, 2021
Enrollment StartMar 4, 2021
Primary CompletionApr 12, 2023
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 5.0 years ago

Interventions

Platelet-rich plasmadevice

Blood will be drawn from a vein in the patient's arm into an 11 ml Eclipse platelet-rich plasma Tube. The blood is processed using a centrifuge machine from eclipse medical. After centrifugation, the platelet poor portion will be separated from the platelet-rich portion. The proximal nail folds are cleansed with alcohol. Using a 1ml syringe and 30g needle, 0.1-0.2 ml of platelet-rich plasma is injected into 8 proximal nail folds.

Platelet-poor plasmadevice

Blood will be drawn from a vein in the patient's arm into an 11 ml Eclipse platelet-rich plasma Tube. The blood is processed using a centrifuge machine from eclipse medical. After centrifugation, the platelet poor portion will be separated from the platelet-rich portion. The proximal nail folds are cleansed with alcohol. Using a 1ml syringe and 30g needle, 0.1-0.2 ml of platelet-poor plasma is injected into 2 proximal nail folds.